What is De Quervain's tenosynovitis?

De Quervain's disease — inflammation and thickening of the tendon sheaths of the extensor pollicis brevis (EPB) and abductor pollicis longus (APL) thumb tendons in the first extensor compartment of the wrist. The tendons swell and cannot glide freely, causing pain.

Common cause — repetitive movements: computer work (mouse), childcare («mommy's wrist»), gardening, sports (tennis, golf). Occurs in 0.5-1.3% of the population, women are affected 6-10 times more often.

Symptoms:

  • Pain in the wrist area on the thumb side
  • Worsens with grasping, wrist rotation, lifting objects
  • Positive Finkelstein's test (sharp pain with ulnar deviation)
  • Swelling in the styloid process area
  • Crepitus with thumb movement

Risk factors:

  • New mothers (lifting and holding child)
  • Computer work (mouse, keyboard)
  • Rheumatoid Arthritis
  • Hormonal changes (pregnancy, menopause)

Facts about De Quervain's

  • ICD-10: M65.4
  • Prevalence: 0.5-1.3% of population
  • Gender: women 6-10 times more often
  • Age: 30-50 years
  • «Mommy's wrist»: typical name

How MIBRAR® treats De Quervain's disease

01

Ultrasound diagnostics

Sono Control Arm™ visualizes thickened tendons, inflamed sheath, presence of septa (partitions) in the first compartment.

02

Obtaining concentrates

CGF — powerful anti-inflammatory factors. Lipogems® — stem cells for regeneration of damaged tendons and reduction of sheath fibrosis.

03

Injection into tendon sheath

Under ultrasound guidance, concentrates are injected directly into the first extensor compartment — to the inflamed EPB and APL tendons.

04

Elimination of inflammation and regeneration

Anti-inflammatory factors reduce swelling, stem cells restore tendon structure. Unlike steroids — long-term effect without weakening tendons.

MIBRAR® Method Advantages

95% of interventions covered

MIBRAR® covers up to 95% of all spinal neurosurgery and orthopedic operations.

No anesthesia or incisions

Outpatient treatment via 0.3-1.5 mm puncture. No general anesthesia or hospitalization.

No age restrictions

Regeneration at any age. Safe for chronic conditions and anesthesia intolerance.

Rapid improvement

Concentrates have analgesic and anti-inflammatory properties. Relief within days.

Multiple zones at once

Simultaneous treatment of multiple discs or joints in one procedure.

Home the same day

No crutches, braces or rehabilitation needed. MRI follow-up at 8-16 weeks.

MIBRAR® Technology

Cyber Navi Hand™ — MIBRAR® navigation system

Cyber Navi Hand™

Intraoperative robotic navigation system. Provides precise access to deep structures with 1 mm and 1 degree accuracy.

Sono Control Arm™ — MIBRAR® ultrasound control

Sono Control Arm™

Device for intervention under sonographic control. Eliminates open surgeries with real-time visual monitoring.

Video about the MIBRAR® Method

Frequently Asked Questions about De Quervain's Treatment

Why is MIBRAR® better than corticosteroid injections?
Steroids relieve inflammation for 4-12 weeks, but repeated injections weaken tendons (risk of rupture), cause skin depigmentation, and subcutaneous fat atrophy. MIBRAR® relieves inflammation and simultaneously regenerates tendons — long-term effect without side effects.
How quickly will the pain go away?
Pain reduction — within the first days. Significant improvement — in 1-2 weeks. Complete tendon regeneration — 4-6 weeks. Temporary restriction of provoking movements is recommended.
Is MIBRAR® safe during breastfeeding?
Yes. MIBRAR® uses exclusively autologous (patient's own) cells — from the patient's blood and adipose tissue. No synthetic drugs. This is safe during pregnancy and breastfeeding, unlike steroids and NSAIDs.

Ready to get rid of pain?

Get a consultation for your case

Book a Consultation